Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
K Hoang-Xuan, E Bessell, J Bromberg… - The Lancet …, 2015 - thelancet.com
The management of primary CNS lymphoma is one of the most controversial topics in neuro-
oncology because of the complexity of the disease and the very few controlled studies …
oncology because of the complexity of the disease and the very few controlled studies …
Primary central nervous system lymphoma
Primary CNS lymphomas (PCNSL) represent a subgroup of malignancies with specific
characteristics, aggressive course, and unsatisfactory outcome in contrast with other …
characteristics, aggressive course, and unsatisfactory outcome in contrast with other …
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience
Purpose: To identify survival predictors and to design a prognostic score useful for
distinguishing risk groups in immunocompetent patients with primary CNS lymphomas …
distinguishing risk groups in immunocompetent patients with primary CNS lymphomas …
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model
LE Abrey, L Ben-Porat, KS Panageas… - Journal of Clinical …, 2006 - ascopubs.org
Purpose The purpose of this study was to analyze prognostic factors for patients with newly
diagnosed primary CNS lymphoma (PCNSL) in order to establish a predictive model that …
diagnosed primary CNS lymphoma (PCNSL) in order to establish a predictive model that …
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular …
C Soussain, F Suzan, K Hoang-Xuan… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: To assess the feasibility and efficacy of intensive chemotherapy with
hematopoietic stem-cell rescue (IC+ HCR) in patients with refractory or recurrent primary …
hematopoietic stem-cell rescue (IC+ HCR) in patients with refractory or recurrent primary …
A medical research council randomized trial in patients with primary cerebral non‐Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide …
GM Mead, NM Bleehen, A Gregor… - … Journal of the …, 2000 - Wiley Online Library
BACKGROUND The role of chemotherapy in the treatment of patients with primary central
nervous system lymphoma (PCL) remains unclear, with no randomized trials available to aid …
nervous system lymphoma (PCL) remains unclear, with no randomized trials available to aid …
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization …
K Hoang-Xuan, L Taillandier, O Chinot… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To assess the efficacy and toxicity of chemotherapy alone in patients older than 60
years with primary CNS lymphoma. Patients and Methods: Fifty patients with a median age …
years with primary CNS lymphoma. Patients and Methods: Fifty patients with a median age …
BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma
KM Braaten, RA Betensky, L De Leval, Y Okada… - Clinical Cancer …, 2003 - AACR
Purpose: The purpose of this study was to investigate the histogenetic origin of primary
central nervous system lymphoma (PCNSL) with respect to stage of B-cell differentiation and …
central nervous system lymphoma (PCNSL) with respect to stage of B-cell differentiation and …
[HTML][HTML] Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
DD Correa, L Maron, H Harder, M Klein, CL Armstrong… - Annals of oncology, 2007 - Elsevier
Background: Treatment-related neurotoxicity has been recognized as a significant problem
in patients with primary central nervous system lymphoma (PCNSL) as effective treatment …
in patients with primary central nervous system lymphoma (PCNSL) as effective treatment …
Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma
PURPOSE: To assess, in a multi-institutional setting, the impact on relapse, survival, and
toxicity of adding two cycles of intravenous methotrexate to cranial irradiation for …
toxicity of adding two cycles of intravenous methotrexate to cranial irradiation for …